nodes	percent_of_prediction	percent_of_DWPC	metapath
Liotrix—SLCO1A2—epilepsy syndrome	0.245	0.735	CbGaD
Liotrix—SLCO1C1—Phenytoin—epilepsy syndrome	0.0758	0.202	CbGbCtD
Liotrix—ALB—epilepsy syndrome	0.0451	0.136	CbGaD
Liotrix—ABCB1—epilepsy syndrome	0.0431	0.129	CbGaD
Liotrix—ALB—Oxcarbazepine—epilepsy syndrome	0.024	0.064	CbGbCtD
Liotrix—ALB—Fosphenytoin—epilepsy syndrome	0.0209	0.0559	CbGbCtD
Liotrix—ALB—Clonazepam—epilepsy syndrome	0.0189	0.0506	CbGbCtD
Liotrix—CYP2C8—Trimethadione—epilepsy syndrome	0.0172	0.046	CbGbCtD
Liotrix—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0162	0.0432	CbGbCtD
Liotrix—ALB—Rufinamide—epilepsy syndrome	0.0154	0.0412	CbGbCtD
Liotrix—SLC22A8—Valproic Acid—epilepsy syndrome	0.0151	0.0405	CbGbCtD
Liotrix—ABCB1—Levetiracetam—epilepsy syndrome	0.0137	0.0366	CbGbCtD
Liotrix—ALB—Phenytoin—epilepsy syndrome	0.0135	0.036	CbGbCtD
Liotrix—ALB—Propofol—epilepsy syndrome	0.0126	0.0336	CbGbCtD
Liotrix—CYP2C8—Carbamazepine—epilepsy syndrome	0.0116	0.0311	CbGbCtD
Liotrix—ALB—Diazepam—epilepsy syndrome	0.0114	0.0305	CbGbCtD
Liotrix—CYP2C8—Primidone—epilepsy syndrome	0.0109	0.029	CbGbCtD
Liotrix—CYP2C8—Phenytoin—epilepsy syndrome	0.0104	0.0279	CbGbCtD
Liotrix—CYP2C8—Propofol—epilepsy syndrome	0.00972	0.026	CbGbCtD
Liotrix—ABCB1—Clobazam—epilepsy syndrome	0.0095	0.0254	CbGbCtD
Liotrix—CYP2C8—Phenobarbital—epilepsy syndrome	0.00929	0.0248	CbGbCtD
Liotrix—ABCB1—Lamotrigine—epilepsy syndrome	0.00914	0.0244	CbGbCtD
Liotrix—CYP2C8—Diazepam—epilepsy syndrome	0.00881	0.0235	CbGbCtD
Liotrix—ABCB1—Carbamazepine—epilepsy syndrome	0.00787	0.021	CbGbCtD
Liotrix—ABCB1—Phenytoin—epilepsy syndrome	0.00706	0.0189	CbGbCtD
Liotrix—CYP2C8—Valproic Acid—epilepsy syndrome	0.00695	0.0186	CbGbCtD
Liotrix—ABCB1—Phenobarbital—epilepsy syndrome	0.00629	0.0168	CbGbCtD
Liotrix—ABCB1—Midazolam—epilepsy syndrome	0.0062	0.0166	CbGbCtD
Liotrix—ABCB1—Diazepam—epilepsy syndrome	0.00596	0.0159	CbGbCtD
Liotrix—SERPINA7—hindbrain—epilepsy syndrome	0.00263	0.0579	CbGeAlD
Liotrix—SLCO1C1—ganglion—epilepsy syndrome	0.00178	0.0392	CbGeAlD
Liotrix—THRB—hindbrain—epilepsy syndrome	0.00162	0.0358	CbGeAlD
Liotrix—THRA—hindbrain—epilepsy syndrome	0.00162	0.0358	CbGeAlD
Liotrix—TTR—hindbrain—epilepsy syndrome	0.00121	0.0266	CbGeAlD
Liotrix—Levothyroxine—SLCO1A2—epilepsy syndrome	0.00104	0.429	CrCbGaD
Liotrix—SERPINA7—spinal cord—epilepsy syndrome	0.000937	0.0206	CbGeAlD
Liotrix—THRB—brainstem—epilepsy syndrome	0.000931	0.0205	CbGeAlD
Liotrix—THRA—brainstem—epilepsy syndrome	0.000931	0.0205	CbGeAlD
Liotrix—THRA—forebrain—epilepsy syndrome	0.000898	0.0198	CbGeAlD
Liotrix—THRB—forebrain—epilepsy syndrome	0.000898	0.0198	CbGeAlD
Liotrix—THRA—telencephalon—epilepsy syndrome	0.000826	0.0182	CbGeAlD
Liotrix—SLC16A2—forebrain—epilepsy syndrome	0.000814	0.0179	CbGeAlD
Liotrix—SERPINA7—nervous system—epilepsy syndrome	0.000789	0.0174	CbGeAlD
Liotrix—SERPINA7—central nervous system—epilepsy syndrome	0.00076	0.0167	CbGeAlD
Liotrix—SLCO1C1—forebrain—epilepsy syndrome	0.000747	0.0164	CbGeAlD
Liotrix—Liothyronine—SLCO1A2—epilepsy syndrome	0.000744	0.306	CrCbGaD
Liotrix—SERPINA7—cerebellum—epilepsy syndrome	0.000743	0.0164	CbGeAlD
Liotrix—TTR—brainstem—epilepsy syndrome	0.000692	0.0152	CbGeAlD
Liotrix—SLCO1C1—telencephalon—epilepsy syndrome	0.000687	0.0151	CbGeAlD
Liotrix—TTR—forebrain—epilepsy syndrome	0.000667	0.0147	CbGeAlD
Liotrix—TTR—telencephalon—epilepsy syndrome	0.000614	0.0135	CbGeAlD
Liotrix—SLCO4A1—forebrain—epilepsy syndrome	0.000598	0.0132	CbGeAlD
Liotrix—SLC16A2—medulla oblongata—epilepsy syndrome	0.000588	0.0129	CbGeAlD
Liotrix—THRA—spinal cord—epilepsy syndrome	0.000579	0.0127	CbGeAlD
Liotrix—SLCO4A1—telencephalon—epilepsy syndrome	0.00055	0.0121	CbGeAlD
Liotrix—SLC16A2—spinal cord—epilepsy syndrome	0.000524	0.0115	CbGeAlD
Liotrix—THRA—head—epilepsy syndrome	0.000514	0.0113	CbGeAlD
Liotrix—THRB—head—epilepsy syndrome	0.000514	0.0113	CbGeAlD
Liotrix—SLCO1C1—midbrain—epilepsy syndrome	0.000493	0.0109	CbGeAlD
Liotrix—THRB—nervous system—epilepsy syndrome	0.000488	0.0107	CbGeAlD
Liotrix—THRA—nervous system—epilepsy syndrome	0.000488	0.0107	CbGeAlD
Liotrix—TTR—medulla oblongata—epilepsy syndrome	0.000482	0.0106	CbGeAlD
Liotrix—SLCO1C1—spinal cord—epilepsy syndrome	0.000481	0.0106	CbGeAlD
Liotrix—THRB—central nervous system—epilepsy syndrome	0.000469	0.0103	CbGeAlD
Liotrix—THRA—central nervous system—epilepsy syndrome	0.000469	0.0103	CbGeAlD
Liotrix—SLC16A2—head—epilepsy syndrome	0.000466	0.0103	CbGeAlD
Liotrix—THRA—cerebellum—epilepsy syndrome	0.000459	0.0101	CbGeAlD
Liotrix—THRB—cerebellum—epilepsy syndrome	0.000459	0.0101	CbGeAlD
Liotrix—SLC10A1—head—epilepsy syndrome	0.000455	0.01	CbGeAlD
Liotrix—SLC16A2—nervous system—epilepsy syndrome	0.000442	0.00973	CbGeAlD
Liotrix—TTR—midbrain—epilepsy syndrome	0.000441	0.00971	CbGeAlD
Liotrix—SLCO4A1—medulla oblongata—epilepsy syndrome	0.000432	0.00952	CbGeAlD
Liotrix—SLC10A1—nervous system—epilepsy syndrome	0.000431	0.00949	CbGeAlD
Liotrix—TTR—spinal cord—epilepsy syndrome	0.00043	0.00947	CbGeAlD
Liotrix—SLCO1A2—forebrain—epilepsy syndrome	0.000428	0.00944	CbGeAlD
Liotrix—SLCO1C1—head—epilepsy syndrome	0.000428	0.00942	CbGeAlD
Liotrix—SLC16A2—central nervous system—epilepsy syndrome	0.000425	0.00937	CbGeAlD
Liotrix—SLC16A2—cerebellum—epilepsy syndrome	0.000416	0.00915	CbGeAlD
Liotrix—SLC10A1—central nervous system—epilepsy syndrome	0.000415	0.00914	CbGeAlD
Liotrix—SLCO1C1—nervous system—epilepsy syndrome	0.000405	0.00893	CbGeAlD
Liotrix—SLCO4A1—midbrain—epilepsy syndrome	0.000395	0.0087	CbGeAlD
Liotrix—SLCO1A2—telencephalon—epilepsy syndrome	0.000394	0.00868	CbGeAlD
Liotrix—SLCO1C1—central nervous system—epilepsy syndrome	0.00039	0.00859	CbGeAlD
Liotrix—SLCO4A1—spinal cord—epilepsy syndrome	0.000386	0.00849	CbGeAlD
Liotrix—TTR—head—epilepsy syndrome	0.000382	0.00842	CbGeAlD
Liotrix—THRB—brain—epilepsy syndrome	0.000373	0.00821	CbGeAlD
Liotrix—THRA—brain—epilepsy syndrome	0.000373	0.00821	CbGeAlD
Liotrix—TTR—nervous system—epilepsy syndrome	0.000362	0.00798	CbGeAlD
Liotrix—TTR—central nervous system—epilepsy syndrome	0.000349	0.00768	CbGeAlD
Liotrix—SLCO4A1—head—epilepsy syndrome	0.000343	0.00755	CbGeAlD
Liotrix—TTR—cerebellum—epilepsy syndrome	0.000341	0.00751	CbGeAlD
Liotrix—SLC16A2—brain—epilepsy syndrome	0.000338	0.00744	CbGeAlD
Liotrix—SLC10A1—brain—epilepsy syndrome	0.00033	0.00726	CbGeAlD
Liotrix—SLCO4A1—nervous system—epilepsy syndrome	0.000325	0.00715	CbGeAlD
Liotrix—SLCO4A1—central nervous system—epilepsy syndrome	0.000313	0.00689	CbGeAlD
Liotrix—SLCO1C1—brain—epilepsy syndrome	0.00031	0.00682	CbGeAlD
Liotrix—SLCO1A2—medulla oblongata—epilepsy syndrome	0.00031	0.00682	CbGeAlD
Liotrix—SLCO4A1—cerebellum—epilepsy syndrome	0.000306	0.00673	CbGeAlD
Liotrix—SLCO1A2—midbrain—epilepsy syndrome	0.000283	0.00623	CbGeAlD
Liotrix—TTR—brain—epilepsy syndrome	0.000277	0.0061	CbGeAlD
Liotrix—SLCO1A2—spinal cord—epilepsy syndrome	0.000276	0.00608	CbGeAlD
Liotrix—SLC16A10—cerebellum—epilepsy syndrome	0.000268	0.0059	CbGeAlD
Liotrix—SLCO4A1—brain—epilepsy syndrome	0.000248	0.00547	CbGeAlD
Liotrix—SLCO1A2—head—epilepsy syndrome	0.000245	0.0054	CbGeAlD
Liotrix—SLC22A8—head—epilepsy syndrome	0.000234	0.00516	CbGeAlD
Liotrix—SLCO1A2—nervous system—epilepsy syndrome	0.000233	0.00512	CbGeAlD
Liotrix—SLCO1A2—central nervous system—epilepsy syndrome	0.000224	0.00493	CbGeAlD
Liotrix—SLC22A8—nervous system—epilepsy syndrome	0.000222	0.00489	CbGeAlD
Liotrix—SLCO1A2—cerebellum—epilepsy syndrome	0.000219	0.00482	CbGeAlD
Liotrix—SLC22A8—central nervous system—epilepsy syndrome	0.000214	0.00471	CbGeAlD
Liotrix—Levothyroxine—ALB—epilepsy syndrome	0.000193	0.0791	CrCbGaD
Liotrix—Levothyroxine—ABCB1—epilepsy syndrome	0.000184	0.0755	CrCbGaD
Liotrix—SLCO1A2—brain—epilepsy syndrome	0.000178	0.00392	CbGeAlD
Liotrix—ALB—brain—epilepsy syndrome	0.000177	0.00389	CbGeAlD
Liotrix—SLC22A8—brain—epilepsy syndrome	0.00017	0.00374	CbGeAlD
Liotrix—ABCB1—forebrain—epilepsy syndrome	0.000144	0.00316	CbGeAlD
Liotrix—Liothyronine—ALB—epilepsy syndrome	0.000137	0.0564	CrCbGaD
Liotrix—ABCB1—telencephalon—epilepsy syndrome	0.000132	0.00291	CbGeAlD
Liotrix—Liothyronine—ABCB1—epilepsy syndrome	0.000131	0.0538	CrCbGaD
Liotrix—CYP2C8—brain—epilepsy syndrome	0.000124	0.00274	CbGeAlD
Liotrix—ABCB1—medulla oblongata—epilepsy syndrome	0.000104	0.00228	CbGeAlD
Liotrix—ABCB1—midbrain—epilepsy syndrome	9.48e-05	0.00209	CbGeAlD
Liotrix—ABCB1—spinal cord—epilepsy syndrome	9.25e-05	0.00204	CbGeAlD
Liotrix—ABCB1—head—epilepsy syndrome	8.22e-05	0.00181	CbGeAlD
Liotrix—ABCB1—nervous system—epilepsy syndrome	7.79e-05	0.00172	CbGeAlD
Liotrix—ABCB1—central nervous system—epilepsy syndrome	7.5e-05	0.00165	CbGeAlD
Liotrix—ABCB1—cerebellum—epilepsy syndrome	7.33e-05	0.00161	CbGeAlD
Liotrix—ABCB1—brain—epilepsy syndrome	5.96e-05	0.00131	CbGeAlD
Liotrix—Confusional state—Valproic Acid—epilepsy syndrome	5.75e-05	0.000376	CcSEcCtD
Liotrix—Pruritus—Zonisamide—epilepsy syndrome	5.75e-05	0.000376	CcSEcCtD
Liotrix—Hypersensitivity—Phenytoin—epilepsy syndrome	5.73e-05	0.000375	CcSEcCtD
Liotrix—Flatulence—Gabapentin—epilepsy syndrome	5.71e-05	0.000373	CcSEcCtD
Liotrix—Oedema—Valproic Acid—epilepsy syndrome	5.7e-05	0.000373	CcSEcCtD
Liotrix—Anaphylactic shock—Valproic Acid—epilepsy syndrome	5.7e-05	0.000373	CcSEcCtD
Liotrix—Urticaria—Lamotrigine—epilepsy syndrome	5.7e-05	0.000373	CcSEcCtD
Liotrix—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	5.7e-05	0.000373	CcSEcCtD
Liotrix—Nausea—Propofol—epilepsy syndrome	5.7e-05	0.000372	CcSEcCtD
Liotrix—Tension—Gabapentin—epilepsy syndrome	5.69e-05	0.000372	CcSEcCtD
Liotrix—Vomiting—Fosphenytoin—epilepsy syndrome	5.68e-05	0.000372	CcSEcCtD
Liotrix—Diarrhoea—Felbamate—epilepsy syndrome	5.68e-05	0.000372	CcSEcCtD
Liotrix—Abdominal pain—Lamotrigine—epilepsy syndrome	5.67e-05	0.000371	CcSEcCtD
Liotrix—Body temperature increased—Lamotrigine—epilepsy syndrome	5.67e-05	0.000371	CcSEcCtD
Liotrix—Dysgeusia—Gabapentin—epilepsy syndrome	5.67e-05	0.000371	CcSEcCtD
Liotrix—Dizziness—Diazepam—epilepsy syndrome	5.67e-05	0.000371	CcSEcCtD
Liotrix—Infection—Valproic Acid—epilepsy syndrome	5.67e-05	0.000371	CcSEcCtD
Liotrix—Syncope—Pregabalin—epilepsy syndrome	5.67e-05	0.000371	CcSEcCtD
Liotrix—Rash—Fosphenytoin—epilepsy syndrome	5.64e-05	0.000369	CcSEcCtD
Liotrix—Dermatitis—Fosphenytoin—epilepsy syndrome	5.63e-05	0.000368	CcSEcCtD
Liotrix—Nervousness—Gabapentin—epilepsy syndrome	5.63e-05	0.000368	CcSEcCtD
Liotrix—Asthenia—Clonazepam—epilepsy syndrome	5.62e-05	0.000368	CcSEcCtD
Liotrix—Headache—Fosphenytoin—epilepsy syndrome	5.6e-05	0.000366	CcSEcCtD
Liotrix—Palpitations—Pregabalin—epilepsy syndrome	5.58e-05	0.000365	CcSEcCtD
Liotrix—Asthenia—Phenytoin—epilepsy syndrome	5.58e-05	0.000365	CcSEcCtD
Liotrix—Nausea—Midazolam—epilepsy syndrome	5.57e-05	0.000364	CcSEcCtD
Liotrix—Hypoaesthesia—Topiramate—epilepsy syndrome	5.57e-05	0.000364	CcSEcCtD
Liotrix—Tachycardia—Valproic Acid—epilepsy syndrome	5.57e-05	0.000364	CcSEcCtD
Liotrix—Diarrhoea—Zonisamide—epilepsy syndrome	5.56e-05	0.000364	CcSEcCtD
Liotrix—Loss of consciousness—Pregabalin—epilepsy syndrome	5.55e-05	0.000363	CcSEcCtD
Liotrix—Asthenia—Oxcarbazepine—epilepsy syndrome	5.55e-05	0.000363	CcSEcCtD
Liotrix—Pruritus—Clonazepam—epilepsy syndrome	5.54e-05	0.000362	CcSEcCtD
Liotrix—Vomiting—Vigabatrin—epilepsy syndrome	5.54e-05	0.000362	CcSEcCtD
Liotrix—Hyperhidrosis—Valproic Acid—epilepsy syndrome	5.51e-05	0.000361	CcSEcCtD
Liotrix—Pruritus—Phenytoin—epilepsy syndrome	5.51e-05	0.00036	CcSEcCtD
Liotrix—Nausea—Levetiracetam—epilepsy syndrome	5.5e-05	0.00036	CcSEcCtD
Liotrix—Rash—Vigabatrin—epilepsy syndrome	5.49e-05	0.000359	CcSEcCtD
Liotrix—Dizziness—Felbamate—epilepsy syndrome	5.49e-05	0.000359	CcSEcCtD
Liotrix—Dermatitis—Vigabatrin—epilepsy syndrome	5.49e-05	0.000359	CcSEcCtD
Liotrix—Pruritus—Oxcarbazepine—epilepsy syndrome	5.48e-05	0.000358	CcSEcCtD
Liotrix—Convulsion—Pregabalin—epilepsy syndrome	5.47e-05	0.000358	CcSEcCtD
Liotrix—Hypersensitivity—Carbamazepine—epilepsy syndrome	5.47e-05	0.000358	CcSEcCtD
Liotrix—Vision blurred—Gabapentin—epilepsy syndrome	5.46e-05	0.000357	CcSEcCtD
Liotrix—Headache—Vigabatrin—epilepsy syndrome	5.46e-05	0.000357	CcSEcCtD
Liotrix—Hypertension—Pregabalin—epilepsy syndrome	5.46e-05	0.000357	CcSEcCtD
Liotrix—Vomiting—Diazepam—epilepsy syndrome	5.46e-05	0.000357	CcSEcCtD
Liotrix—Anorexia—Valproic Acid—epilepsy syndrome	5.44e-05	0.000356	CcSEcCtD
Liotrix—Tremor—Gabapentin—epilepsy syndrome	5.43e-05	0.000355	CcSEcCtD
Liotrix—Rash—Diazepam—epilepsy syndrome	5.41e-05	0.000354	CcSEcCtD
Liotrix—Dermatitis—Diazepam—epilepsy syndrome	5.4e-05	0.000353	CcSEcCtD
Liotrix—Chest pain—Pregabalin—epilepsy syndrome	5.38e-05	0.000352	CcSEcCtD
Liotrix—Arthralgia—Pregabalin—epilepsy syndrome	5.38e-05	0.000352	CcSEcCtD
Liotrix—Dizziness—Zonisamide—epilepsy syndrome	5.38e-05	0.000352	CcSEcCtD
Liotrix—Headache—Diazepam—epilepsy syndrome	5.37e-05	0.000352	CcSEcCtD
Liotrix—Anxiety—Pregabalin—epilepsy syndrome	5.36e-05	0.000351	CcSEcCtD
Liotrix—Diarrhoea—Clonazepam—epilepsy syndrome	5.36e-05	0.000351	CcSEcCtD
Liotrix—Hypotension—Valproic Acid—epilepsy syndrome	5.33e-05	0.000349	CcSEcCtD
Liotrix—Asthenia—Carbamazepine—epilepsy syndrome	5.33e-05	0.000349	CcSEcCtD
Liotrix—Agitation—Gabapentin—epilepsy syndrome	5.32e-05	0.000348	CcSEcCtD
Liotrix—Diarrhoea—Phenytoin—epilepsy syndrome	5.32e-05	0.000348	CcSEcCtD
Liotrix—Nausea—Fosphenytoin—epilepsy syndrome	5.31e-05	0.000347	CcSEcCtD
Liotrix—Diarrhoea—Oxcarbazepine—epilepsy syndrome	5.3e-05	0.000346	CcSEcCtD
Liotrix—Angioedema—Gabapentin—epilepsy syndrome	5.29e-05	0.000346	CcSEcCtD
Liotrix—Hypersensitivity—Lamotrigine—epilepsy syndrome	5.29e-05	0.000346	CcSEcCtD
Liotrix—Vomiting—Felbamate—epilepsy syndrome	5.28e-05	0.000345	CcSEcCtD
Liotrix—Pruritus—Carbamazepine—epilepsy syndrome	5.25e-05	0.000344	CcSEcCtD
Liotrix—Rash—Felbamate—epilepsy syndrome	5.24e-05	0.000342	CcSEcCtD
Liotrix—Dermatitis—Felbamate—epilepsy syndrome	5.23e-05	0.000342	CcSEcCtD
Liotrix—Headache—Felbamate—epilepsy syndrome	5.2e-05	0.00034	CcSEcCtD
Liotrix—Confusional state—Pregabalin—epilepsy syndrome	5.2e-05	0.00034	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	5.2e-05	0.00034	CcSEcCtD
Liotrix—Flushing—Topiramate—epilepsy syndrome	5.2e-05	0.00034	CcSEcCtD
Liotrix—Syncope—Gabapentin—epilepsy syndrome	5.2e-05	0.00034	CcSEcCtD
Liotrix—Dizziness—Clonazepam—epilepsy syndrome	5.18e-05	0.000339	CcSEcCtD
Liotrix—Nausea—Vigabatrin—epilepsy syndrome	5.18e-05	0.000339	CcSEcCtD
Liotrix—Vomiting—Zonisamide—epilepsy syndrome	5.17e-05	0.000338	CcSEcCtD
Liotrix—Insomnia—Valproic Acid—epilepsy syndrome	5.16e-05	0.000337	CcSEcCtD
Liotrix—Anaphylactic shock—Pregabalin—epilepsy syndrome	5.16e-05	0.000337	CcSEcCtD
Liotrix—Oedema—Pregabalin—epilepsy syndrome	5.16e-05	0.000337	CcSEcCtD
Liotrix—Asthenia—Lamotrigine—epilepsy syndrome	5.15e-05	0.000337	CcSEcCtD
Liotrix—Dizziness—Phenytoin—epilepsy syndrome	5.15e-05	0.000337	CcSEcCtD
Liotrix—Rash—Zonisamide—epilepsy syndrome	5.12e-05	0.000335	CcSEcCtD
Liotrix—Infection—Pregabalin—epilepsy syndrome	5.12e-05	0.000335	CcSEcCtD
Liotrix—Paraesthesia—Valproic Acid—epilepsy syndrome	5.12e-05	0.000335	CcSEcCtD
Liotrix—Palpitations—Gabapentin—epilepsy syndrome	5.12e-05	0.000335	CcSEcCtD
Liotrix—Dermatitis—Zonisamide—epilepsy syndrome	5.12e-05	0.000335	CcSEcCtD
Liotrix—Dizziness—Oxcarbazepine—epilepsy syndrome	5.12e-05	0.000335	CcSEcCtD
Liotrix—Nausea—Diazepam—epilepsy syndrome	5.1e-05	0.000333	CcSEcCtD
Liotrix—Loss of consciousness—Gabapentin—epilepsy syndrome	5.09e-05	0.000333	CcSEcCtD
Liotrix—Headache—Zonisamide—epilepsy syndrome	5.09e-05	0.000333	CcSEcCtD
Liotrix—Dyspnoea—Valproic Acid—epilepsy syndrome	5.09e-05	0.000333	CcSEcCtD
Liotrix—Diarrhoea—Carbamazepine—epilepsy syndrome	5.08e-05	0.000332	CcSEcCtD
Liotrix—Pruritus—Lamotrigine—epilepsy syndrome	5.08e-05	0.000332	CcSEcCtD
Liotrix—Shock—Pregabalin—epilepsy syndrome	5.07e-05	0.000332	CcSEcCtD
Liotrix—Tachycardia—Pregabalin—epilepsy syndrome	5.03e-05	0.000329	CcSEcCtD
Liotrix—Convulsion—Gabapentin—epilepsy syndrome	5.02e-05	0.000328	CcSEcCtD
Liotrix—Hypertension—Gabapentin—epilepsy syndrome	5e-05	0.000327	CcSEcCtD
Liotrix—Hyperhidrosis—Pregabalin—epilepsy syndrome	4.99e-05	0.000326	CcSEcCtD
Liotrix—Vomiting—Clonazepam—epilepsy syndrome	4.98e-05	0.000326	CcSEcCtD
Liotrix—Decreased appetite—Valproic Acid—epilepsy syndrome	4.96e-05	0.000324	CcSEcCtD
Liotrix—Alopecia—Topiramate—epilepsy syndrome	4.95e-05	0.000324	CcSEcCtD
Liotrix—Vomiting—Phenytoin—epilepsy syndrome	4.95e-05	0.000324	CcSEcCtD
Liotrix—Rash—Clonazepam—epilepsy syndrome	4.94e-05	0.000323	CcSEcCtD
Liotrix—Dermatitis—Clonazepam—epilepsy syndrome	4.93e-05	0.000323	CcSEcCtD
Liotrix—Arthralgia—Gabapentin—epilepsy syndrome	4.93e-05	0.000323	CcSEcCtD
Liotrix—Chest pain—Gabapentin—epilepsy syndrome	4.93e-05	0.000323	CcSEcCtD
Liotrix—Nausea—Felbamate—epilepsy syndrome	4.93e-05	0.000323	CcSEcCtD
Liotrix—Vomiting—Oxcarbazepine—epilepsy syndrome	4.92e-05	0.000322	CcSEcCtD
Liotrix—Fatigue—Valproic Acid—epilepsy syndrome	4.92e-05	0.000322	CcSEcCtD
Liotrix—Anxiety—Gabapentin—epilepsy syndrome	4.92e-05	0.000321	CcSEcCtD
Liotrix—Anorexia—Pregabalin—epilepsy syndrome	4.92e-05	0.000321	CcSEcCtD
Liotrix—Dizziness—Carbamazepine—epilepsy syndrome	4.91e-05	0.000321	CcSEcCtD
Liotrix—Diarrhoea—Lamotrigine—epilepsy syndrome	4.91e-05	0.000321	CcSEcCtD
Liotrix—Headache—Clonazepam—epilepsy syndrome	4.91e-05	0.000321	CcSEcCtD
Liotrix—Rash—Phenytoin—epilepsy syndrome	4.91e-05	0.000321	CcSEcCtD
Liotrix—Dermatitis—Phenytoin—epilepsy syndrome	4.9e-05	0.000321	CcSEcCtD
Liotrix—Rash—Oxcarbazepine—epilepsy syndrome	4.88e-05	0.000319	CcSEcCtD
Liotrix—Constipation—Valproic Acid—epilepsy syndrome	4.88e-05	0.000319	CcSEcCtD
Liotrix—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.88e-05	0.000319	CcSEcCtD
Liotrix—Headache—Phenytoin—epilepsy syndrome	4.87e-05	0.000319	CcSEcCtD
Liotrix—Headache—Oxcarbazepine—epilepsy syndrome	4.85e-05	0.000317	CcSEcCtD
Liotrix—Nausea—Zonisamide—epilepsy syndrome	4.83e-05	0.000316	CcSEcCtD
Liotrix—Hypotension—Pregabalin—epilepsy syndrome	4.82e-05	0.000315	CcSEcCtD
Liotrix—Flatulence—Topiramate—epilepsy syndrome	4.8e-05	0.000314	CcSEcCtD
Liotrix—Tension—Topiramate—epilepsy syndrome	4.78e-05	0.000313	CcSEcCtD
Liotrix—Dysgeusia—Topiramate—epilepsy syndrome	4.77e-05	0.000312	CcSEcCtD
Liotrix—Confusional state—Gabapentin—epilepsy syndrome	4.77e-05	0.000312	CcSEcCtD
Liotrix—Dizziness—Lamotrigine—epilepsy syndrome	4.75e-05	0.00031	CcSEcCtD
Liotrix—Nervousness—Topiramate—epilepsy syndrome	4.73e-05	0.00031	CcSEcCtD
Liotrix—Oedema—Gabapentin—epilepsy syndrome	4.73e-05	0.000309	CcSEcCtD
Liotrix—Anaphylactic shock—Gabapentin—epilepsy syndrome	4.73e-05	0.000309	CcSEcCtD
Liotrix—Vomiting—Carbamazepine—epilepsy syndrome	4.72e-05	0.000309	CcSEcCtD
Liotrix—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.7e-05	0.000307	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	4.7e-05	0.000307	CcSEcCtD
Liotrix—Infection—Gabapentin—epilepsy syndrome	4.7e-05	0.000307	CcSEcCtD
Liotrix—Rash—Carbamazepine—epilepsy syndrome	4.68e-05	0.000306	CcSEcCtD
Liotrix—Dermatitis—Carbamazepine—epilepsy syndrome	4.68e-05	0.000306	CcSEcCtD
Liotrix—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.66e-05	0.000305	CcSEcCtD
Liotrix—Insomnia—Pregabalin—epilepsy syndrome	4.66e-05	0.000305	CcSEcCtD
Liotrix—Nausea—Clonazepam—epilepsy syndrome	4.65e-05	0.000304	CcSEcCtD
Liotrix—Headache—Carbamazepine—epilepsy syndrome	4.65e-05	0.000304	CcSEcCtD
Liotrix—Shock—Gabapentin—epilepsy syndrome	4.65e-05	0.000304	CcSEcCtD
Liotrix—Paraesthesia—Pregabalin—epilepsy syndrome	4.63e-05	0.000303	CcSEcCtD
Liotrix—Nausea—Phenytoin—epilepsy syndrome	4.62e-05	0.000302	CcSEcCtD
Liotrix—Tachycardia—Gabapentin—epilepsy syndrome	4.62e-05	0.000302	CcSEcCtD
Liotrix—Dyspnoea—Pregabalin—epilepsy syndrome	4.6e-05	0.000301	CcSEcCtD
Liotrix—Nausea—Oxcarbazepine—epilepsy syndrome	4.6e-05	0.000301	CcSEcCtD
Liotrix—Vision blurred—Topiramate—epilepsy syndrome	4.59e-05	0.0003	CcSEcCtD
Liotrix—Hyperhidrosis—Gabapentin—epilepsy syndrome	4.57e-05	0.000299	CcSEcCtD
Liotrix—Tremor—Topiramate—epilepsy syndrome	4.57e-05	0.000299	CcSEcCtD
Liotrix—Vomiting—Lamotrigine—epilepsy syndrome	4.56e-05	0.000298	CcSEcCtD
Liotrix—Urticaria—Valproic Acid—epilepsy syndrome	4.53e-05	0.000296	CcSEcCtD
Liotrix—Rash—Lamotrigine—epilepsy syndrome	4.53e-05	0.000296	CcSEcCtD
Liotrix—Dermatitis—Lamotrigine—epilepsy syndrome	4.52e-05	0.000296	CcSEcCtD
Liotrix—Abdominal pain—Valproic Acid—epilepsy syndrome	4.51e-05	0.000295	CcSEcCtD
Liotrix—Body temperature increased—Valproic Acid—epilepsy syndrome	4.51e-05	0.000295	CcSEcCtD
Liotrix—Anorexia—Gabapentin—epilepsy syndrome	4.51e-05	0.000295	CcSEcCtD
Liotrix—Headache—Lamotrigine—epilepsy syndrome	4.5e-05	0.000294	CcSEcCtD
Liotrix—Decreased appetite—Pregabalin—epilepsy syndrome	4.48e-05	0.000293	CcSEcCtD
Liotrix—Agitation—Topiramate—epilepsy syndrome	4.48e-05	0.000293	CcSEcCtD
Liotrix—Fatigue—Pregabalin—epilepsy syndrome	4.45e-05	0.000291	CcSEcCtD
Liotrix—Hypotension—Gabapentin—epilepsy syndrome	4.42e-05	0.000289	CcSEcCtD
Liotrix—Nausea—Carbamazepine—epilepsy syndrome	4.41e-05	0.000289	CcSEcCtD
Liotrix—Constipation—Pregabalin—epilepsy syndrome	4.41e-05	0.000288	CcSEcCtD
Liotrix—Syncope—Topiramate—epilepsy syndrome	4.37e-05	0.000286	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	4.31e-05	0.000282	CcSEcCtD
Liotrix—Palpitations—Topiramate—epilepsy syndrome	4.31e-05	0.000282	CcSEcCtD
Liotrix—Loss of consciousness—Topiramate—epilepsy syndrome	4.28e-05	0.00028	CcSEcCtD
Liotrix—Insomnia—Gabapentin—epilepsy syndrome	4.28e-05	0.00028	CcSEcCtD
Liotrix—Nausea—Lamotrigine—epilepsy syndrome	4.26e-05	0.000279	CcSEcCtD
Liotrix—Feeling abnormal—Pregabalin—epilepsy syndrome	4.25e-05	0.000278	CcSEcCtD
Liotrix—Paraesthesia—Gabapentin—epilepsy syndrome	4.25e-05	0.000278	CcSEcCtD
Liotrix—Convulsion—Topiramate—epilepsy syndrome	4.22e-05	0.000276	CcSEcCtD
Liotrix—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.22e-05	0.000276	CcSEcCtD
Liotrix—Dyspnoea—Gabapentin—epilepsy syndrome	4.22e-05	0.000276	CcSEcCtD
Liotrix—Hypertension—Topiramate—epilepsy syndrome	4.21e-05	0.000275	CcSEcCtD
Liotrix—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.2e-05	0.000275	CcSEcCtD
Liotrix—Arthralgia—Topiramate—epilepsy syndrome	4.15e-05	0.000271	CcSEcCtD
Liotrix—Chest pain—Topiramate—epilepsy syndrome	4.15e-05	0.000271	CcSEcCtD
Liotrix—Anxiety—Topiramate—epilepsy syndrome	4.14e-05	0.00027	CcSEcCtD
Liotrix—Decreased appetite—Gabapentin—epilepsy syndrome	4.11e-05	0.000269	CcSEcCtD
Liotrix—Urticaria—Pregabalin—epilepsy syndrome	4.1e-05	0.000268	CcSEcCtD
Liotrix—Asthenia—Valproic Acid—epilepsy syndrome	4.09e-05	0.000268	CcSEcCtD
Liotrix—Fatigue—Gabapentin—epilepsy syndrome	4.08e-05	0.000267	CcSEcCtD
Liotrix—Body temperature increased—Pregabalin—epilepsy syndrome	4.08e-05	0.000267	CcSEcCtD
Liotrix—Abdominal pain—Pregabalin—epilepsy syndrome	4.08e-05	0.000267	CcSEcCtD
Liotrix—Constipation—Gabapentin—epilepsy syndrome	4.04e-05	0.000264	CcSEcCtD
Liotrix—Pruritus—Valproic Acid—epilepsy syndrome	4.04e-05	0.000264	CcSEcCtD
Liotrix—Confusional state—Topiramate—epilepsy syndrome	4.01e-05	0.000262	CcSEcCtD
Liotrix—Oedema—Topiramate—epilepsy syndrome	3.98e-05	0.00026	CcSEcCtD
Liotrix—Infection—Topiramate—epilepsy syndrome	3.95e-05	0.000258	CcSEcCtD
Liotrix—Shock—Topiramate—epilepsy syndrome	3.91e-05	0.000256	CcSEcCtD
Liotrix—Diarrhoea—Valproic Acid—epilepsy syndrome	3.9e-05	0.000255	CcSEcCtD
Liotrix—Feeling abnormal—Gabapentin—epilepsy syndrome	3.9e-05	0.000255	CcSEcCtD
Liotrix—Tachycardia—Topiramate—epilepsy syndrome	3.88e-05	0.000254	CcSEcCtD
Liotrix—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.87e-05	0.000253	CcSEcCtD
Liotrix—Hyperhidrosis—Topiramate—epilepsy syndrome	3.85e-05	0.000252	CcSEcCtD
Liotrix—Hypersensitivity—Pregabalin—epilepsy syndrome	3.8e-05	0.000248	CcSEcCtD
Liotrix—Anorexia—Topiramate—epilepsy syndrome	3.79e-05	0.000248	CcSEcCtD
Liotrix—Dizziness—Valproic Acid—epilepsy syndrome	3.77e-05	0.000247	CcSEcCtD
Liotrix—Urticaria—Gabapentin—epilepsy syndrome	3.76e-05	0.000246	CcSEcCtD
Liotrix—Body temperature increased—Gabapentin—epilepsy syndrome	3.74e-05	0.000244	CcSEcCtD
Liotrix—Abdominal pain—Gabapentin—epilepsy syndrome	3.74e-05	0.000244	CcSEcCtD
Liotrix—Hypotension—Topiramate—epilepsy syndrome	3.72e-05	0.000243	CcSEcCtD
Liotrix—Asthenia—Pregabalin—epilepsy syndrome	3.7e-05	0.000242	CcSEcCtD
Liotrix—Pruritus—Pregabalin—epilepsy syndrome	3.65e-05	0.000239	CcSEcCtD
Liotrix—Vomiting—Valproic Acid—epilepsy syndrome	3.63e-05	0.000237	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.62e-05	0.000237	CcSEcCtD
Liotrix—Insomnia—Topiramate—epilepsy syndrome	3.6e-05	0.000235	CcSEcCtD
Liotrix—Rash—Valproic Acid—epilepsy syndrome	3.6e-05	0.000235	CcSEcCtD
Liotrix—Dermatitis—Valproic Acid—epilepsy syndrome	3.59e-05	0.000235	CcSEcCtD
Liotrix—Headache—Valproic Acid—epilepsy syndrome	3.57e-05	0.000234	CcSEcCtD
Liotrix—Paraesthesia—Topiramate—epilepsy syndrome	3.57e-05	0.000234	CcSEcCtD
Liotrix—Dyspnoea—Topiramate—epilepsy syndrome	3.55e-05	0.000232	CcSEcCtD
Liotrix—Diarrhoea—Pregabalin—epilepsy syndrome	3.53e-05	0.000231	CcSEcCtD
Liotrix—Hypersensitivity—Gabapentin—epilepsy syndrome	3.48e-05	0.000228	CcSEcCtD
Liotrix—Decreased appetite—Topiramate—epilepsy syndrome	3.46e-05	0.000226	CcSEcCtD
Liotrix—Fatigue—Topiramate—epilepsy syndrome	3.43e-05	0.000224	CcSEcCtD
Liotrix—Dizziness—Pregabalin—epilepsy syndrome	3.41e-05	0.000223	CcSEcCtD
Liotrix—Constipation—Topiramate—epilepsy syndrome	3.4e-05	0.000222	CcSEcCtD
Liotrix—Asthenia—Gabapentin—epilepsy syndrome	3.39e-05	0.000222	CcSEcCtD
Liotrix—Nausea—Valproic Acid—epilepsy syndrome	3.39e-05	0.000222	CcSEcCtD
Liotrix—Pruritus—Gabapentin—epilepsy syndrome	3.35e-05	0.000219	CcSEcCtD
Liotrix—Vomiting—Pregabalin—epilepsy syndrome	3.28e-05	0.000214	CcSEcCtD
Liotrix—Feeling abnormal—Topiramate—epilepsy syndrome	3.28e-05	0.000214	CcSEcCtD
Liotrix—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.25e-05	0.000213	CcSEcCtD
Liotrix—Rash—Pregabalin—epilepsy syndrome	3.25e-05	0.000213	CcSEcCtD
Liotrix—Dermatitis—Pregabalin—epilepsy syndrome	3.25e-05	0.000212	CcSEcCtD
Liotrix—Diarrhoea—Gabapentin—epilepsy syndrome	3.24e-05	0.000212	CcSEcCtD
Liotrix—Headache—Pregabalin—epilepsy syndrome	3.23e-05	0.000211	CcSEcCtD
Liotrix—Urticaria—Topiramate—epilepsy syndrome	3.16e-05	0.000207	CcSEcCtD
Liotrix—Abdominal pain—Topiramate—epilepsy syndrome	3.14e-05	0.000206	CcSEcCtD
Liotrix—Body temperature increased—Topiramate—epilepsy syndrome	3.14e-05	0.000206	CcSEcCtD
Liotrix—Dizziness—Gabapentin—epilepsy syndrome	3.13e-05	0.000205	CcSEcCtD
Liotrix—Nausea—Pregabalin—epilepsy syndrome	3.06e-05	0.0002	CcSEcCtD
Liotrix—Vomiting—Gabapentin—epilepsy syndrome	3.01e-05	0.000197	CcSEcCtD
Liotrix—Rash—Gabapentin—epilepsy syndrome	2.98e-05	0.000195	CcSEcCtD
Liotrix—Dermatitis—Gabapentin—epilepsy syndrome	2.98e-05	0.000195	CcSEcCtD
Liotrix—Headache—Gabapentin—epilepsy syndrome	2.96e-05	0.000194	CcSEcCtD
Liotrix—Hypersensitivity—Topiramate—epilepsy syndrome	2.93e-05	0.000192	CcSEcCtD
Liotrix—Asthenia—Topiramate—epilepsy syndrome	2.85e-05	0.000187	CcSEcCtD
Liotrix—Pruritus—Topiramate—epilepsy syndrome	2.81e-05	0.000184	CcSEcCtD
Liotrix—Nausea—Gabapentin—epilepsy syndrome	2.81e-05	0.000184	CcSEcCtD
Liotrix—Diarrhoea—Topiramate—epilepsy syndrome	2.72e-05	0.000178	CcSEcCtD
Liotrix—Dizziness—Topiramate—epilepsy syndrome	2.63e-05	0.000172	CcSEcCtD
Liotrix—Vomiting—Topiramate—epilepsy syndrome	2.53e-05	0.000165	CcSEcCtD
Liotrix—Rash—Topiramate—epilepsy syndrome	2.51e-05	0.000164	CcSEcCtD
Liotrix—Dermatitis—Topiramate—epilepsy syndrome	2.51e-05	0.000164	CcSEcCtD
Liotrix—Headache—Topiramate—epilepsy syndrome	2.49e-05	0.000163	CcSEcCtD
Liotrix—Nausea—Topiramate—epilepsy syndrome	2.36e-05	0.000155	CcSEcCtD
Liotrix—TTR—Signaling Pathways—NGF—epilepsy syndrome	6.47e-06	7.03e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	6.44e-06	7.01e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—HSD17B4—epilepsy syndrome	6.43e-06	7e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	6.42e-06	6.99e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—SLCO1A2—epilepsy syndrome	6.4e-06	6.97e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PFKL—epilepsy syndrome	6.4e-06	6.97e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—KCNB1—epilepsy syndrome	6.4e-06	6.97e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CACNA2D2—epilepsy syndrome	6.4e-06	6.97e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—SLC6A8—epilepsy syndrome	6.4e-06	6.97e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6.39e-06	6.96e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CCR5—epilepsy syndrome	6.29e-06	6.84e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—NOS1—epilepsy syndrome	6.27e-06	6.82e-05	CbGpPWpGaD
Liotrix—SLC22A8—Transmembrane transport of small molecules—ALB—epilepsy syndrome	6.27e-06	6.82e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GBE1—epilepsy syndrome	6.25e-06	6.8e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PPP1R3C—epilepsy syndrome	6.25e-06	6.8e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PPP1R3C—epilepsy syndrome	6.21e-06	6.76e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—GBE1—epilepsy syndrome	6.21e-06	6.76e-05	CbGpPWpGaD
Liotrix—TTR—Disease—FGF2—epilepsy syndrome	6.21e-06	6.75e-05	CbGpPWpGaD
Liotrix—ABCB1—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	6.18e-06	6.72e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—HTR2A—epilepsy syndrome	6.16e-06	6.7e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	6.11e-06	6.64e-05	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	6.11e-06	6.64e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	6.07e-06	6.61e-05	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	5.95e-06	6.47e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ASAH1—epilepsy syndrome	5.87e-06	6.39e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—AKT3—epilepsy syndrome	5.87e-06	6.39e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.86e-06	6.37e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—UPB1—epilepsy syndrome	5.86e-06	6.37e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NEU1—epilepsy syndrome	5.86e-06	6.37e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ATIC—epilepsy syndrome	5.86e-06	6.37e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TSC2—epilepsy syndrome	5.85e-06	6.36e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ASAH1—epilepsy syndrome	5.84e-06	6.36e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—AGT—epilepsy syndrome	5.84e-06	6.35e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—CYP2D6—epilepsy syndrome	5.84e-06	6.35e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	5.82e-06	6.33e-05	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—POMC—epilepsy syndrome	5.81e-06	6.32e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PLAUR—epilepsy syndrome	5.8e-06	6.31e-05	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	5.77e-06	6.28e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—APOE—epilepsy syndrome	5.72e-06	6.23e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—STXBP1—epilepsy syndrome	5.71e-06	6.22e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ABCG2—epilepsy syndrome	5.71e-06	6.21e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—STXBP1—epilepsy syndrome	5.68e-06	6.18e-05	CbGpPWpGaD
Liotrix—TTR—Disease—MTOR—epilepsy syndrome	5.65e-06	6.15e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	5.64e-06	6.13e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—KDR—epilepsy syndrome	5.61e-06	6.1e-05	CbGpPWpGaD
Liotrix—TTR—Disease—PTGS2—epilepsy syndrome	5.6e-06	6.09e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NT5E—epilepsy syndrome	5.57e-06	6.06e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ALAD—epilepsy syndrome	5.57e-06	6.06e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	5.57e-06	6.06e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CYP2C19—epilepsy syndrome	5.57e-06	6.06e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—ADRA2A—epilepsy syndrome	5.56e-06	6.05e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ALAD—epilepsy syndrome	5.54e-06	6.02e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—NT5E—epilepsy syndrome	5.54e-06	6.02e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—BCHE—epilepsy syndrome	5.53e-06	6.02e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CYP11A1—epilepsy syndrome	5.53e-06	6.02e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	5.53e-06	6.01e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—HMOX1—epilepsy syndrome	5.53e-06	6.01e-05	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	5.51e-06	5.99e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.49e-06	5.98e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—CAT—epilepsy syndrome	5.45e-06	5.93e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GBE1—epilepsy syndrome	5.44e-06	5.92e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	5.44e-06	5.92e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PRKCB—epilepsy syndrome	5.4e-06	5.87e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—IL6ST—epilepsy syndrome	5.38e-06	5.85e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—CDC42—epilepsy syndrome	5.36e-06	5.83e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ALDH7A1—epilepsy syndrome	5.31e-06	5.78e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CACNA1A—epilepsy syndrome	5.31e-06	5.78e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—ABCB1—epilepsy syndrome	5.31e-06	5.77e-05	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—ALB—epilepsy syndrome	5.3e-06	5.77e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ALDH7A1—epilepsy syndrome	5.28e-06	5.75e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CACNA1A—epilepsy syndrome	5.28e-06	5.75e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—SLC2A1—epilepsy syndrome	5.28e-06	5.74e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	5.25e-06	5.71e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PLCB1—epilepsy syndrome	5.22e-06	5.68e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—TH—epilepsy syndrome	5.2e-06	5.66e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ST3GAL3—epilepsy syndrome	5.2e-06	5.66e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ST3GAL3—epilepsy syndrome	5.17e-06	5.62e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	5.12e-06	5.57e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ASAH1—epilepsy syndrome	5.12e-06	5.57e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ADSL—epilepsy syndrome	5.09e-06	5.54e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ADSL—epilepsy syndrome	5.06e-06	5.51e-05	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	5.06e-06	5.5e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.01e-06	5.45e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GLUL—epilepsy syndrome	5e-06	5.43e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CYP2D6—epilepsy syndrome	4.99e-06	5.43e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—STXBP1—epilepsy syndrome	4.98e-06	5.42e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—GLUL—epilepsy syndrome	4.97e-06	5.4e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—GPX1—epilepsy syndrome	4.93e-06	5.37e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—POMC—epilepsy syndrome	4.92e-06	5.35e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CACNA1D—epilepsy syndrome	4.9e-06	5.33e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	4.88e-06	5.3e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CACNA1D—epilepsy syndrome	4.88e-06	5.3e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ALAD—epilepsy syndrome	4.85e-06	5.28e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NT5E—epilepsy syndrome	4.85e-06	5.28e-05	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	4.83e-06	5.25e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CCL2—epilepsy syndrome	4.81e-06	5.23e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—FYN—epilepsy syndrome	4.77e-06	5.19e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	4.76e-06	5.18e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ADRA2A—epilepsy syndrome	4.75e-06	5.17e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	4.74e-06	5.15e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—BCHE—epilepsy syndrome	4.73e-06	5.15e-05	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PTGS2—epilepsy syndrome	4.64e-06	5.04e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	4.63e-06	5.04e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	4.63e-06	5.04e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—TXNRD1—epilepsy syndrome	4.59e-06	4.99e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—YWHAZ—epilepsy syndrome	4.59e-06	4.99e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—TXNRD1—epilepsy syndrome	4.56e-06	4.96e-05	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	4.53e-06	4.93e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	4.53e-06	4.93e-05	CbGpPWpGaD
Liotrix—TTR—Disease—SRC—epilepsy syndrome	4.53e-06	4.93e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—SLC2A1—epilepsy syndrome	4.52e-06	4.91e-05	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—AVP—epilepsy syndrome	4.49e-06	4.89e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PLCB1—epilepsy syndrome	4.47e-06	4.86e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—AQP1—epilepsy syndrome	4.45e-06	4.84e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—TH—epilepsy syndrome	4.45e-06	4.84e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ADSL—epilepsy syndrome	4.44e-06	4.83e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—AQP1—epilepsy syndrome	4.43e-06	4.82e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.38e-06	4.77e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GLUL—epilepsy syndrome	4.35e-06	4.73e-05	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	4.35e-06	4.73e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—FGF2—epilepsy syndrome	4.35e-06	4.73e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—HMOX1—epilepsy syndrome	4.34e-06	4.73e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—AGT—epilepsy syndrome	4.33e-06	4.71e-05	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	4.31e-06	4.69e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—CAT—epilepsy syndrome	4.29e-06	4.66e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.28e-06	4.65e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	4.27e-06	4.65e-05	CbGpPWpGaD
Liotrix—THRB—Gene Expression—AKT1—epilepsy syndrome	4.25e-06	4.63e-05	CbGpPWpGaD
Liotrix—THRA—Gene Expression—AKT1—epilepsy syndrome	4.25e-06	4.63e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.25e-06	4.63e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	4.25e-06	4.62e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—APOE—epilepsy syndrome	4.24e-06	4.61e-05	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	4.2e-06	4.57e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—ABCB1—epilepsy syndrome	4.17e-06	4.54e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	4.14e-06	4.5e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PLAU—epilepsy syndrome	4.07e-06	4.43e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—RELA—epilepsy syndrome	4.04e-06	4.39e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	4.03e-06	4.38e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	4.03e-06	4.38e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CHRM3—epilepsy syndrome	4e-06	4.36e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—KCNJ11—epilepsy syndrome	4e-06	4.36e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	4e-06	4.35e-05	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.97e-06	4.32e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MTOR—epilepsy syndrome	3.96e-06	4.31e-05	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.93e-06	4.28e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—AQP1—epilepsy syndrome	3.88e-06	4.22e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—GPX1—epilepsy syndrome	3.88e-06	4.22e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PRKCB—epilepsy syndrome	3.78e-06	4.12e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.75e-06	4.08e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—NOS2—epilepsy syndrome	3.74e-06	4.07e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.73e-06	4.06e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—HMOX1—epilepsy syndrome	3.71e-06	4.04e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.67e-06	4e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CAT—epilepsy syndrome	3.66e-06	3.99e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.65e-06	3.97e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—POMC—epilepsy syndrome	3.64e-06	3.96e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CASP3—epilepsy syndrome	3.64e-06	3.96e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ABCB1—epilepsy syndrome	3.56e-06	3.88e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	3.55e-06	3.86e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—JUN—epilepsy syndrome	3.54e-06	3.85e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CHRM3—epilepsy syndrome	3.51e-06	3.82e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	3.51e-06	3.82e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MMP9—epilepsy syndrome	3.44e-06	3.74e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—AGT—epilepsy syndrome	3.4e-06	3.7e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—APOE—epilepsy syndrome	3.33e-06	3.62e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—ALB—epilepsy syndrome	3.32e-06	3.61e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GPX1—epilepsy syndrome	3.31e-06	3.61e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	3.28e-06	3.57e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ABCG2—epilepsy syndrome	3.26e-06	3.55e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	3.2e-06	3.48e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP2C19—epilepsy syndrome	3.18e-06	3.46e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	3.18e-06	3.46e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—SRC—epilepsy syndrome	3.17e-06	3.45e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP11A1—epilepsy syndrome	3.16e-06	3.44e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.16e-06	3.43e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.14e-06	3.41e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—VEGFA—epilepsy syndrome	3.09e-06	3.36e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—AGT—epilepsy syndrome	2.91e-06	3.16e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PTGS2—epilepsy syndrome	2.9e-06	3.16e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.88e-06	3.13e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	2.87e-06	3.12e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—POMC—epilepsy syndrome	2.86e-06	3.11e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ABCG2—epilepsy syndrome	2.86e-06	3.11e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP2D6—epilepsy syndrome	2.85e-06	3.1e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—APOE—epilepsy syndrome	2.85e-06	3.1e-05	CbGpPWpGaD
Liotrix—TTR—Disease—AKT1—epilepsy syndrome	2.81e-06	3.06e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	2.79e-06	3.03e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	2.77e-06	3.01e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	2.73e-06	2.97e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—BCHE—epilepsy syndrome	2.72e-06	2.96e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ADRA2A—epilepsy syndrome	2.72e-06	2.95e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—BCHE—epilepsy syndrome	2.7e-06	2.94e-05	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	2.68e-06	2.92e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.64e-06	2.87e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—ALB—epilepsy syndrome	2.61e-06	2.84e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	2.59e-06	2.82e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—SLC2A1—epilepsy syndrome	2.58e-06	2.81e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	2.57e-06	2.79e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—TH—epilepsy syndrome	2.56e-06	2.78e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PLCB1—epilepsy syndrome	2.55e-06	2.78e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—TH—epilepsy syndrome	2.54e-06	2.77e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.52e-06	2.74e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.5e-06	2.72e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	2.5e-06	2.72e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—POMC—epilepsy syndrome	2.45e-06	2.66e-05	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.38e-06	2.59e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	2.38e-06	2.59e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—BCHE—epilepsy syndrome	2.37e-06	2.58e-05	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—AKT1—epilepsy syndrome	2.33e-06	2.54e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PTGS2—epilepsy syndrome	2.28e-06	2.48e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	2.26e-06	2.46e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PLCB1—epilepsy syndrome	2.24e-06	2.43e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ALB—epilepsy syndrome	2.23e-06	2.43e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—TH—epilepsy syndrome	2.23e-06	2.42e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—SRC—epilepsy syndrome	2.22e-06	2.42e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—VEGFA—epilepsy syndrome	2.17e-06	2.36e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	2.13e-06	2.32e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—HMOX1—epilepsy syndrome	2.12e-06	2.31e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CAT—epilepsy syndrome	2.11e-06	2.29e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CAT—epilepsy syndrome	2.09e-06	2.28e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	2.05e-06	2.23e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ABCB1—epilepsy syndrome	2.04e-06	2.22e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—AKT1—epilepsy syndrome	1.97e-06	2.14e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PTGS2—epilepsy syndrome	1.95e-06	2.12e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GPX1—epilepsy syndrome	1.9e-06	2.07e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—GPX1—epilepsy syndrome	1.89e-06	2.06e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—HMOX1—epilepsy syndrome	1.86e-06	2.02e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CAT—epilepsy syndrome	1.83e-06	2e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—AGT—epilepsy syndrome	1.67e-06	1.82e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—AGT—epilepsy syndrome	1.66e-06	1.81e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.66e-06	1.81e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—APOE—epilepsy syndrome	1.64e-06	1.78e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—APOE—epilepsy syndrome	1.63e-06	1.77e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—AKT1—epilepsy syndrome	1.46e-06	1.59e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—AGT—epilepsy syndrome	1.45e-06	1.58e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—APOE—epilepsy syndrome	1.43e-06	1.55e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—POMC—epilepsy syndrome	1.41e-06	1.53e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—POMC—epilepsy syndrome	1.4e-06	1.52e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—AKT1—epilepsy syndrome	1.38e-06	1.5e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ALB—epilepsy syndrome	1.28e-06	1.39e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—POMC—epilepsy syndrome	1.22e-06	1.33e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—AKT1—epilepsy syndrome	1.15e-06	1.25e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	1.12e-06	1.22e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ALB—epilepsy syndrome	1.12e-06	1.21e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PTGS2—epilepsy syndrome	1.11e-06	1.21e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—AKT1—epilepsy syndrome	9.81e-07	1.07e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PTGS2—epilepsy syndrome	9.77e-07	1.06e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—AKT1—epilepsy syndrome	5.63e-07	6.13e-06	CbGpPWpGaD
Liotrix—ALB—Metabolism—AKT1—epilepsy syndrome	5.6e-07	6.1e-06	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—AKT1—epilepsy syndrome	4.91e-07	5.34e-06	CbGpPWpGaD
